세계의 첨단 창상관리 시장 규모, 점유율, 동향 분석 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Advanced Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial), By Application (Chronic Wounds, Acute Wounds), By End-use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

첨단 창상관리 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 첨단 창상관리 시장 규모는 2025-2030년에 CAGR 4.79%로 확대하며, 2030년에는 148억 7,000만 달러에 달할 전망입니다.

고령화 인구 증가와 당뇨병 환자 증가는 이 시장의 성장을 가속하는 주요 요인입니다.

예를 들어 United Health Foundation의 보고서(2023년 5월 발행)에 따르면 미국에는 65세 이상 성인이 5,580만 명 이상 거주하고 있으며, 2021년에는 미국 인구의 약 16.8%를 차지하고 있습니다.

세계에서 외과수술 및 외상 사고가 증가하고 있습니다. 예를 들어 Research Gate의 조사에 따르면 2022년에는 매년 약 6.6%의 사망률이 외상으로 인해 발생한다고 합니다. 마찬가지로 수술 부위 감염도 증가하고 있습니다. 첨단 상처 관리 제품은 이러한 수술 부위 감염을 억제하고 감소시키는 데 도움이 되므로 수술 부위 감염 증가는 예측 기간 중 시장을 주도할 것으로 예상됩니다.

COVID-19 백신의 도입과 봉쇄 조치의 해제는 예측 기간 중 시장에 긍정적인 영향을 미칠 것으로 예상됩니다. 연기되었던 많은 선택적 수술이 시행될 것으로 예상됩니다. 이와 더불어, 많은 주요 제조업체들이 신제품을 출시하고 있으며, 이는 예측 기간 중 첨단 상처 관리 제품에 대한 수요 증가를 포착하는 데 도움이 될 것으로 예상됩니다.

첨단 상처 관리 시장 보고서 하이라이트

• 제품별로는 습윤 상처 관리 분야가 2024년 70.75%로 가장 큰 매출 점유율을 차지하며 시장을 선도했습니다. 이러한 우위는 상처 사례 증가와 전 세계 수술 건수 증가에 기인합니다.
• 용도별로는 만성 상처 분야가 2024년 가장 큰 매출 점유율을 차지하며 시장을 독점하고 있습니다. 당뇨병성 족부궤양, 정맥성 욕창, 기타 만성 상처 증가가 이 분야의 성장을 촉진할 것으로 보입니다.
• 최종 용도별로는 병원 부문이 2024년 45.37%의 가장 큰 매출 점유율을 차지하고 있습니다. 이 부문의 성장은 외과수술의 급증과 입원 환자 수 증가에 기인합니다.
• 북미는 2024년 45.47%의 매출 점유율로 시장을 장악했습니다. 이러한 우위는 잘 정비된 의료 인프라와 수술 건수 증가에 기인합니다.
• 아시아태평양은 예측 기간 중 가장 빠른 CAGR을 보일 것으로 예상됩니다. 이는 주요 기업의 존재, 만성질환의 유병률 증가, 의료비 지출 증가에 기인합니다.

목차

제1장 분석 방법·범위

제2장 개요

제3장 첨단 창상관리 시장 : 변동 요인·동향·범위

• 시장 연관 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 첨단 창상관리 시장 : 분석 툴
  • 업계 분석 : Porter의 산업 분석
  • PESTEL 분석

제4장 첨단 창상관리 시장 : 제품별 추정·동향 분석

• 부문 대시보드
• 세계의 첨단 창상관리 시장의 변동 분석 : 제품별
• 세계의 첨단 창상관리 시장 규모와 동향 분석 : 제품별(2018-2030년)
• 습윤
  • 발포 피복재
  • 하이드로콜로이드 피복재
  • 필름식 피복재
  • 알긴산염피복재
  • 하이드로겔 피복재
  • 콜라겐 피복재
  • 기타 첨단 피복재
• 항균성
  • 은
  • 은 이외
• 액티브
  • 바이오소재
  • 피부 대체품
  • 성장 요인

제5장 첨단 창상관리 시장 : 용도별 추정·동향 분석

• 부문 대시보드
• 세계의 첨단 창상관리 시장의 변동 분석 : 용도별
• 세계의 첨단 창상관리 시장 규모와 동향 분석 : 용도별(2018-2030년)
• 만성 창상
  • 당뇨병성 족궤양
  • 욕창
  • 정맥성 하지 궤양
  • 기타 만성 창상
• 급성 창상
  • 수술창·외상
  • 화상

제6장 첨단 창상관리 시장 : 최종 용도별 추정·동향 분석

• 부문 대시보드
• 세계의 첨단 창상관리 시장의 변동 분석 : 최종 용도별
• 세계의 첨단 창상관리 시장 규모와 동향 분석 : 최종 용도별(2018-2030년)
• 병원
• 전문 클리닉
• 재택 의료
• 기타

제7장 첨단 창상관리 시장 : 지역별 추정·동향 분석(제품별, 용도별, 최종 용도별)

• 시장 점유율 분석 : 지역별(2024년·2030년)
• 시장 대시보드 : 지역별
• 시장 규모 예측과 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 구도

• 기업/경쟁 분류
• 전략 지도제작
• 기업의 시장 포지션 분석(2023년)
• 기업 개요/상장기업
  • ConvaTec Group PLC
  • Smith &Nephew PLC
  • Molnlycke Health Care AB
  • B. Braun Melsungen AG
  • 3M
  • URGO
  • Coloplast Corp.
  • Integra LifeSciences
  • Medline Industries, Inc.

KSA

영문 목차

영문목차

Advanced Wound Care Market Growth & Trends:

The global advanced wound care market size is expected to reach USD 14.87 billion by 2030, expanding at a CAGR of 4.79% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growth in the number of the aging population as well as an increasing figure of diabetic patients are some major factors driving this market's growth.

For instance, as per a United Health Foundation report (published in May 2023), more than 55.8 million adults aged 65 and older lived in the U.S., accounting for about 16.8% of the nation's population in 2021, increasing the number of senior populations is anticipated to propel the market during the forecast period.

There has been growth in the number of surgical procedures, and traumatic incidents globally. For instance, as per a study by Research Gate, in 2022, around 6.6% of mortality occurs due to trauma every year. Similarly, there has been an increase in the number of surgical site infections. Advanced wound care products help to contain and reduce these surgical site infections, thereby, an increase in the number of surgical site infections is expected to drive the market during the forecast period.

The introduction of the COVID-19 vaccine, and the lifting of lockdown impositions, are expected to have a positive impact on the market over the forecast period. Many elective surgeries, which were postponed, are expected to take place. In addition to this, many leading manufacturers are introducing new products which may help them to capitalize on the increasing demand for advanced wound care products during the forecast period.

Advanced Wound Care Market Report Highlights:

• Based on product, the moist wound care segment led the market with the largest revenue share of 70.75% in 2024. This dominance can be attributed to an increase in a number of wound cases and increase in number of surgeries globally.
• In terms of application, the chronic wounds segment is dominating the market with the largest revenue share in 2024. Increasing number of diabetic foot ulcers, venous pressure ulcers, and other chronic wounds is expected to drive the segment growth.
• Based on end-use, the hospital segment held the market with the largest revenue share of 45.37% in 2024. The growth of this segment can be attributed to the upsurge in surgical procedures and increase in the number of hospital admissions.
• North America dominated the market with the revenue share of 45.47% in 2024. This dominance can be attributed to well-developed healthcare infrastructure and increase in the number of surgical procedures.
• Asia Pacific is anticipated to witness fastest CAGR during the forecast period. This can be attributed to the presence of major key players, the increasing prevalence of chronic disorders, and rising healthcare expenditure.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Application Segment
  • 1.2.3. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Advanced Wound Care Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
    • 3.2.1.2. Introduction of innovative and advanced wound products
    • 3.2.1.3. Rising geriatric population
    • 3.2.1.4. Increasing number of road accidents, trauma cases, and burns
    • 3.2.1.5. Increasing number of surgeries
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Delayed Diagnosis and lower treatment rates in emerging nations
• 3.3. Advanced Wound Care Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Advanced Wound Care Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Advanced Wound Care Market Product Movement Analysis
• 4.3. Global Advanced Wound Care Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Moist
  • 4.4.1. Moist market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Foam Dressings
    • 4.4.2.1. Foam dressings market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Hydrocolloid Dressings
    • 4.4.3.1. Hydrocolloid dressings market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Film Dressings
    • 4.4.4.1. Film dressings market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Alginate Dressings
    • 4.4.5.1. Alginate dressings market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.6. Hydrogel Dressings
    • 4.4.6.1. Hydrogel dressings market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.7. Collagen Dressings
    • 4.4.7.1. Hydrocolloid dressings market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.8. Other Advanced Dressings
    • 4.4.8.1. Other advanced dressings market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Antimicrobial
  • 4.5.1. Antimicrobial market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Silver
    • 4.5.2.1. Silver market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Non-silver
    • 4.5.3.1. Non-silver market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Active
  • 4.6.1. Active market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.2. Biomaterials
    • 4.6.2.1. Biomaterials market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.3. Skin-substitute
    • 4.6.3.1. Skin-substitute market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.4. Growth Factors
    • 4.6.4.1. Growth factors market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Advanced Wound Care Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Advanced Wound Care Market Application Movement Analysis
• 5.3. Global Advanced Wound Care Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Chronic Wounds
  • 5.4.1. Chronic wounds market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Diabetic Foot Ulcers
    • 5.4.2.1. Diabetic foot ulcers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Pressure Ulcers
    • 5.4.3.1. Pressure ulcers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Venous Leg Ulcers
    • 5.4.4.1. Venous leg ulcers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Other Chronic Wounds
    • 5.4.5.1. Other chronic wounds market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Acute Wounds
  • 5.5.1. Acute wounds market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.2. Surgical & Traumatic Wounds
    • 5.5.2.1. Surgical & traumatic wounds market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.3. Burns
    • 5.5.3.1. Burns market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Advanced Wound Care Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Advanced Wound Care Market End Use Movement Analysis
• 6.3. Global Advanced Wound Care Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Specialty Clinics
  • 6.5.1. Specialty Clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Home Healthcare
  • 6.6.1. Home healthcare market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Advanced Wound Care Market: Regional Estimates & Trend Analysis By Product, Application, and End Use

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Competitive scenario
    • 7.4.1.3. Regulatory framework
    • 7.4.1.4. Reimbursement scenario
    • 7.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Mexico
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Competitive scenario
    • 7.5.1.3. Regulatory framework
    • 7.5.1.4. Reimbursement scenario
    • 7.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Competitive scenario
    • 7.5.8.3. Regulatory framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement scenario
    • 7.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Argentina
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement scenario
    • 7.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Competitive scenario
    • 7.8.4.3. Regulatory framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2023
• 8.4. Company Profiles/Listing
  • 8.4.1. ConvaTec Group PLC
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Smith & Nephew PLC
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Molnlycke Health Care AB
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. B. Braun Melsungen AG
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. 3M
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. URGO
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Coloplast Corp.
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Integra LifeSciences
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Medline Industries, Inc.
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives

관련자료